Ketoprofen/Gabapentin

酮洛芬/加巴喷丁

Report date: 2024/07/17 16:06:21

Base Information

Drug NameKetoprofen/Gabapentin
Drug Alias NameKetoprofen Lysine Salt combined with GabapentinCo-crystal KLS-Gaba (Dompe)DFL-24412KLS-GABA
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenase-1 inhibitorsCyclooxygenase-2 inhibitorsLipoxygenase inhibitors +[5] 
TargetsCyclooxygenase-2Cyclooxygenase-1Lipoxygenase +[5] 
Therapy Area/IndicationsBack Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsYes KetoprofenGabapentin
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDompé Pharmaceutici Spa
China Registration ClassN/A

Develop Information

Active CompaniesDompé Pharmaceutici Spa
Inactive CompaniesN/A
Active IndicationsBack Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A